These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9563065)

  • 1. Drug exsorption from blood into the gastrointestinal tract.
    Arimori K; Nakano M
    Pharm Res; 1998 Mar; 15(3):371-6. PubMed ID: 9563065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological role of P-glycoprotein in the intestinal epithelium.
    Van Asperen J; Van Tellingen O; Beijnen JH
    Pharmacol Res; 1998 Jun; 37(6):429-35. PubMed ID: 9695116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary components on the gastrointestinal metabolism and transport of drugs.
    Evans AM
    Ther Drug Monit; 2000 Feb; 22(1):131-6. PubMed ID: 10688276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of the function of small intestinal P-glycoprotein: comparative studies between in situ and in vitro.
    Adachi Y; Suzuki H; Sugiyama Y
    Pharm Res; 2003 Aug; 20(8):1163-9. PubMed ID: 12948013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of oral bioavailability of anticancer drugs: from mouse to man.
    Schellens JH; Malingré MM; Kruijtzer CM; Bardelmeijer HA; van Tellingen O; Schinkel AH; Beijnen JH
    Eur J Pharm Sci; 2000 Dec; 12(2):103-10. PubMed ID: 11102737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
    Kwon H; Lionberger RA; Yu LX
    Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
    Neuhoff S; Ungell AL; Zamora I; Artursson P
    Pharm Res; 2003 Aug; 20(8):1141-8. PubMed ID: 12948010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.
    Saitoh H; Aungst BJ
    Pharm Res; 1995 Sep; 12(9):1304-10. PubMed ID: 8570526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of expression/function of intestinal P-glycoprotein under disease states.
    Murakami T; Bodor E; Bodor N
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):59-78. PubMed ID: 31821048
    [No Abstract]   [Full Text] [Related]  

  • 12. Intestinal drug transporters: in vivo function and clinical importance.
    Kunta JR; Sinko PJ
    Curr Drug Metab; 2004 Feb; 5(1):109-24. PubMed ID: 14965254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting intestinal transporters for optimizing oral drug absorption.
    Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
    Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Drug or Food with Drug Transporters in Intestine and Liver.
    Nakanishi T; Tamai I
    Curr Drug Metab; 2015; 16(9):753-64. PubMed ID: 26630906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats.
    Arimori K; Kuroki N; Hidaka M; Iwakiri T; Yamsaki K; Okumura M; Ono H; Takamura N; Kikuchi M; Nakano M
    Pharm Res; 2003 Jun; 20(6):910-7. PubMed ID: 12817897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.
    Karlsson J; Kuo SM; Ziemniak J; Artursson P
    Br J Pharmacol; 1993 Nov; 110(3):1009-16. PubMed ID: 7905337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
    Fromm MF
    Int J Clin Pharmacol Ther; 2000 Feb; 38(2):69-74. PubMed ID: 10706193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular characterization of intestinal absorption of drugs by carrier-mediated transport mechanisms].
    Tamai I
    Yakugaku Zasshi; 1997 Jul; 117(7):415-34. PubMed ID: 9261213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.
    Tam D; Tirona RG; Pang KS
    Drug Metab Dispos; 2003 Apr; 31(4):373-83. PubMed ID: 12642462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.